ArticleNature neuroscience2023
Author Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.
Open access · bronzeAbstract readPublished Erratum
In one paragraph
Article in Nature neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Interdisciplinary collaborative teaching in vascular surgery training: A randomized trial of radiologist-surgeon partnership in China.PloS one · 2026Trial
- LRP10 and α-synuclein transmission in Lewy body diseases.Cellular and molecular life sciences : CMLS · 2024Article
Corrections and comments
- Erratum for
Authors and funding
23 authors at 7 institutions in 3 countries.
Shujing Zhang *Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-7658-8192
Ruowei Zhu *Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Buyan PanDepartment of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1876-0326
Hong XuThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Modupe F OlufemiThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ronald J GathaganThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Yuanxi LiDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Luyan ZhangDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Jasmine ZhangDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Wenxuan XiangDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Eliot Masahiro KaganDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Xingjun CaoInnovent Biologics, Inc., Suzhou, China.
Chaoxing YuanAlexion Pharmaceuticals, Inc., New Haven, CT, USA.
Soo-Jung KimThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Christopher K WilliamsSection of Neuropathology, Department of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Shino MagakiSection of Neuropathology, Department of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Harry V VintersSection of Neuropathology, Department of Pathology and Laboratory Medicine, Department of Neurology, and Brain Research Institute, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA, USA.
Hilal A LashuelLaboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Swiss Federal Institute of Technology, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-7682-8320
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University St Louis, St Louis, MO, USA.
E James PeterssonDepartment of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
John Q TrojanowskiThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Virginia M-Y LeeThe Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. vmylee@upenn.edu.ORCID http://orcid.org/0000-0003-3536-6902
Chao PengDepartment of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA. cpeng@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-1994-2087
University of California, Los Angeles · USInstitute on Aging · USUniversity of Pennsylvania · USAlexion Pharmaceuticals (United States) · USEast China University of Science and Technology · CNÉcole Polytechnique Fédérale de Lausanne · CHWashington University in St. Louis · US
Funding
Regulation of Pathological Tau Transmission by Soluble Tau Post-Translational ModificationsR01NS128964 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Chao Peng · 2022 to 2026
$3.4MStudying Aggregation in Neurodegenerative Disease Using Synthetic ProteinsR01NS103873 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Ernest James Petersson · 2019 to 2026
$2.1MCurePSP 672-2020-12U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS128964U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS53488U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS103873
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.